In October 2019, our firm—along with co-counsel Tom Kline from Kline and Specter—won a record-breaking $8 billion punitive damage verdict against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, the makers of a medication called Risperdal. Our client suffered from a condition known as gynecomastia—the growth of female breasts on boys—after taking Risperdal.
Johnson & Johnson originally developed Risperdal to treat schizophrenia in adults. In order to make more profits Johnson & Johnson marketed the drug off-label to children. Johnson & Johnson withheld scientific data from the public showing that the drug caused this serious deformity in young boys. Johnson & Johnson hurt the most vulnerable members of our society just to make a few more dollars.
The jury sent Johnson & Johnson a message: it is not acceptable to knowing hurt children. Johnson & Johnson needs to change its ways.
The $8 billion verdict set multiple records. It is the third largest jury verdict ever obtained for an individual plaintiff in the United States, and it is the largest single-plaintiff jury verdict ever won in Pennsylvania.